Insiders bought 244K on the open market and sold nothing.
Get an email when LEEEF's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Jun 15 | Kevin John Wilson Chief Financial Officer | Bought | 464,197 | $0.23 | 107K | New | Form 4 |
| May 18 | Robert James Mendola Jr Director | Bought | 357,553 | $0.25 | 89K | New | Form 4 |
| May 18 | Kevin John Wilson Chief Financial Officer | Bought | 54,348 | $0.25 | 14K | 6.4% | Form 4 |
| May 18 | Micah Payne Anderson Chief Executive Officer | Bought | 135,870 | $0.25 | 34K | 0.9% | Form 4 |
- Jun 15Kevin John WilsonChief Financial Officer · bought 464,197 at $0.23107KNew position
- May 18Robert James Mendola JrDirector · bought 357,553 at $0.2589KNew position
- May 18Kevin John WilsonChief Financial Officer · bought 54,348 at $0.2514K6.4% of stake
- May 18Micah Payne AndersonChief Executive Officer · bought 135,870 at $0.2534K0.9% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Medicinal Chemicals & Botanical Products · Pick stocks to compare with LEEEF
Spot a number that looks wrong? Check it in LEEEF's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing LEEEF
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.